Dumont & Blake Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.28M Sell
13,416
-540
-4% -$126K 0.82% 25
2025
Q4
$2.89M Sell
13,956
-17
-0.1% -$3.36K 0.69% 32
2025
Q3
$2.59M Sell
13,973
-5
-0% -$857 0.63% 39
2025
Q2
$2.14M Sell
13,978
-388
-3% -$59.6K 0.56% 47
2025
Q1
$2.38M Buy
14,366
+55
+0.4% +$8.61K 0.67% 37
2024
Q4
$2.07M Sell
14,311
-25
-0.2% -$3.87K 0.56% 43
2024
Q3
$2.32M Sell
14,336
-14,483
-50% -$2.31M 0.62% 37
2024
Q2
$4.21M Buy
28,819
+13,269
+85% +$1.97M 0.6% 40
2024
Q1
$2.46M Sell
15,550
-530
-3% -$84.4K 0.71% 35
2023
Q4
$2.52M Sell
16,080
-422
-3% -$64.7K 0.78% 27
2023
Q3
$2.57M Sell
16,502
-26
-0.2% -$4.29K 0.87% 24
2023
Q2
$2.74M Sell
16,528
-153
-0.9% -$24.7K 0.89% 20
2023
Q1
$2.58M Sell
16,681
-300
-2% -$48.4K 0.88% 22
2022
Q4
$3M Sell
16,981
-49
-0.3% -$8.46K 1.06% 17
2022
Q3
$2.78M Sell
17,030
-1,021
-6% -$173K 1.04% 17
2022
Q2
$3.2M Sell
18,051
-699
-4% -$125K 1.05% 16
2022
Q1
$3.32M Sell
18,750
-425
-2% -$72.3K 0.91% 21
2021
Q4
$3.28M Sell
19,175
-14
-0.1% -$2.29K 0.85% 26
2021
Q3
$3.1M Sell
19,189
-148
-0.8% -$25.3K 0.89% 26
2021
Q2
$3.19M Buy
19,337
+61
+0.3% +$10.1K 0.91% 23
2021
Q1
$3.17M Sell
19,276
-240
-1% -$38.8K 0.97% 19
2020
Q4
$3.07M Sell
19,516
-419
-2% -$61.8K 1.05% 18
2020
Q3
$2.97M Sell
19,935
-80
-0.4% -$11.8K 1.13% 17
2020
Q2
$2.81M Sell
20,015
-13
-0.1% -$1.89K 1.18% 17
2020
Q1
$2.63M Sell
20,028
-768
-4% -$109K 1.35% 15
2019
Q4
$3.03M Buy
20,796
+71
+0.3% +$9.63K 1.19% 18
2019
Q3
$2.68M Sell
20,725
-610
-3% -$80.4K 1.13% 20
2019
Q2
$2.97M Sell
21,335
-504
-2% -$69.8K 1.24% 18
2019
Q1
$3.05M Buy
21,839
+140
+0.6% +$18.8K 1.29% 16
2018
Q4
$2.8M Sell
21,699
-204
-0.9% -$28.5K 1.31% 16
2018
Q3
$3.03M Buy
21,903
+345
+2% +$45.8K 1.18% 18
2018
Q2
$2.62M Buy
21,558
+605
+3% +$75.5K 1.1% 20
2018
Q1
$2.69M Hold
20,953
1.14% 21
2017
Q4
$2.93M Sell
20,953
-220
-1% -$30.6K 1.19% 16
2017
Q3
$2.75M Sell
21,173
-109
-0.5% -$14.4K 1.18% 17
2017
Q2
$2.81M Buy
21,282
+87
+0.4% +$11.1K 1.25% 18
2017
Q1
$2.64M Buy
21,195
+222
+1% +$26.5K 1.19% 18
2016
Q4
$2.42M Buy
20,973
+50
+0.2% +$5.78K 1.13% 21
2016
Q3
$2.47M Sell
20,923
-1,605
-7% -$195K 1.21% 18
2016
Q2
$2.73M Sell
22,528
-200
-0.9% -$22.7K 1.37% 16
2016
Q1
$2.46M Sell
22,728
-189
-0.8% -$19.6K 1.27% 16
2015
Q4
$2.35M Buy
22,917
+1,140
+5% +$115K 1.2% 19
2015
Q3
$2.03M Sell
21,777
-201
-0.9% -$19.4K 1.1% 21
2015
Q2
$2.14M Buy
21,978
+295
+1% +$29.5K 1.05% 25
2015
Q1
$2.18M Buy
21,683
+890
+4% +$90.5K 1.06% 24
2014
Q4
$2.17M Sell
20,793
-83
-0.4% -$8.75K 1.08% 23
2014
Q3
$2.23M Sell
20,876
-1,270
-6% -$132K 1.15% 17
2014
Q2
$2.32M Sell
22,146
-265
-1% -$26.8K 1.16% 18
2014
Q1
$2.2M Sell
22,411
-487
-2% -$45.1K 1.15% 19
2013
Q4
$2.1M Sell
22,898
-6,240
-21% -$575K 1.08% 22
2013
Q3
$2.53M Buy
29,138
+1,225
+4% +$110K 1.2% 16
2013
Q2
$2.4M Buy
+27,913
New +$2.37M 1.44% 12

Other funds holding JNJ

Dumont & Blake Investment Advisors's JNJ Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 3.9% in Q1 2026, selling an estimated $126K and leaving 13,416 shares worth $3.28M. The position accounts for 0.82% of the portfolio, ranked #25.

Dumont & Blake Investment Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.21M in Q2 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Dumont & Blake Investment Advisors held 13,416 shares of Johnson & Johnson worth $3.28M as of Q1 2026.
  • Dumont & Blake Investment Advisors sold 540 Johnson & Johnson shares in Q1 2026, an estimated $126K.
  • Johnson & Johnson made up 0.82% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #25 holding.
  • Dumont & Blake Investment Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's Johnson & Johnson position peaked at $4.21M in Q2 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.